Maverick Therapeutics is now part of Takeda. Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/ Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Maverick’s highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
View Top Employees from Maverick Therapeutics| Website | https://www.mavericktx.com/ |
| Revenue | $3 million |
| Employees | 8 (8 on RocketReach) |
| Founded | 2016 |
| Address | 3260 Bayshore Blvd, Brisbane, California 94005, US |
| Phone | (650) 338-1231 |
| Technologies |
JavaScript,
HTML,
Twitter
+23 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Drug Discovery, Immunooncology, Business Services, Biotechnology |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Maverick Therapeutics employee's phone or email?
Maverick Therapeutics Questions
The Maverick Therapeutics annual revenue was $3 million in 2024.
8 people are employed at Maverick Therapeutics.
Maverick Therapeutics is based in Brisbane, California.
The NAICS codes for Maverick Therapeutics are [54171, 541714, 5417, 541, 54].
The SIC codes for Maverick Therapeutics are [873, 87].
Top Maverick Therapeutics Employees
-
2
-
22
-
11
-
2
-
1
Related Companies
